Founded Date: 2021-01-01
Last Funding Type: Series A
Headquarters: Vancouver, British Columbia, Canada
Investors Number: 6.0
Industry: Early Drug Development
Last Funding Date: 2022-01-31
Funding Status: Early Stage Venture
Total Funding: 40000000.0